PillSafe

PillSafe, based in the US, specializes in delivering innovative AI-driven medication dispensing solutions to enhance patient medication adherence through secure and efficient tracking systems. Founded in Edmond, US, PillSafe offers advanced medication management solutions through a closed-loop AI platform. The company was formed to tackle adherence challenges in healthcare. It has secured funding through a SEED round with participation from Doctor's Orders Infusion Services, LLC.

The most recent deal was completed on March 17, 2026, amounting to an undisclosed sum. PillSafe operates independently without known parent or subsidiary companies. PillSafe offers a pioneering closed-loop AI medication dispensing platform designed to enhance medication adherence through real-time tracking, security, and reporting. This innovative platform creates a seamless connection among pharmacies, providers, and patients, facilitating a comprehensive medication management system that addresses adherence challenges faced by patients.

The platform leverages a Virtual Patient Case Manager, developed in collaboration with Humanate, to ensure precise dosing and adherence to prescribed regimens. This service is particularly valuable for healthcare providers and pharmacies looking to improve patient outcomes, as it enables a continuous, learning interaction among patients, providers, and AI technology. Currently, PillSafe's services are targeted toward healthcare markets in North America and Europe, where they aim to improve medication management and adherence across diverse patient demographics. PillSafe generates revenue through subscription-based models, partnerships with healthcare providers, and direct sales to pharmacies.

The company offers its software as a service (SaaS), allowing clients to access its medication dispensing solutions through a tiered pricing structure based on the scale of use and functionalities required. Clients typically include healthcare institutions and pharmacy networks that seek to integrate PillSafe's technology into their operations. Business transactions are structured to facilitate recurring revenue through monthly or annual subscriptions, ensuring that clients can benefit from ongoing support and system updates. Key products associated with revenue generation include PillSafe's AI-driven medication dispensing system and its associated Virtual Patient Case Manager, both of which are crucial for meeting modern healthcare compliance and patient care standards.

PillSafe aims to enhance its services through the development and launch of new products, which are currently in the design phase. The company plans to expand into additional international markets, specifically targeting regions in Europe by the end of 2026. The recent SEED funding secured in March 2026 will be utilized to support these product development and commercialization initiatives, enabling PillSafe to strengthen its market position and enhance its technology offerings.